首页> 外文会议>International symposium on crystal engineering and drug delivery system >Molecular Packing in Organic Crystals: Interplay between a Molecule’s Conformation and Its Intermolecular Interactions
【24h】

Molecular Packing in Organic Crystals: Interplay between a Molecule’s Conformation and Its Intermolecular Interactions

机译:有机晶体中的分子包装:分子构象之间的相互作用及其分子间相互作用

获取原文
获取外文期刊封面目录资料

摘要

@@McCrone’s statement the number of polymorphs is proportional to the time and money spent in research on that compound has been frequently cited to emphasize the intriguing nature of organic crystals.1 Polymorphism was discovered as early as 1822.2 Given the ability of an organic molecule to change its conformation and exhibit the versatility of spatial packing, it appears that there could be a large number of polymorphs for any given organic molecule. Such a reception has led to both promise and concern in the pharmaceutical industry. On the one hand, a new polymorph may offer additional therapeutic properties and would definitely provide a marketing edge for extending the patent life of “blockbuster” drugs. On the other hand, failure to obtain all possible polymorphs of a new drug can considerably put pressures on the drug development because of potential risk of phase transition that can happen during manufacturing and storage (e.g., the case of ritonavir 3). All of these considerations lead to enormous efforts of polymorph screening. The recent report and debate of the second crystal structure of aspirin may highlight from a different viewpoint the great interest in the area of polymorph study.
机译:@@ MCCRONE的声明,多晶型物的数量与研究中所花费的时间和金钱成比例,该化合物经常被引用,以强调有机晶体的有趣性。如有机分子的能力,如1822.2发现的多态性。改变其构象并表现出空间包装的多功能性,看起来可能对任何给定的有机分子有大量多晶型物。这种接收导致制药行业的承诺和关注。一方面,新的多晶型物可以提供额外的治疗性质,并且肯定会提供用于扩展“破坏炸弹”药物的专利寿命的营销优势。另一方面,由于在制造和储存过程中可能发生的潜在相变风险(例如,Ritonavir 3)可能发生的潜在风险,未能获得新药物的所有可能的多晶型物都可以显着放弃对药物发育的压力(例如,Ritonavir 3的情况)。所有这些考虑都导致多晶型筛查的巨大努力。最近的阿司匹林第二晶体结构的报告和辩论可能会从不同的观点突出显示多晶型研究领域的巨大兴趣。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号